Daiichi Sankyo
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Daiichi Sankyo and other ETFs, options, and stocks.About DSNKY
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin.
CEOHiroyuki Okuzawa
CEOHiroyuki Okuzawa
Employees20,171
Employees20,171
HeadquartersTokyo, Tokyo
HeadquartersTokyo, Tokyo
Founded2005
Founded2005
Employees20,171
Employees20,171
DSNKY Key Statistics
Market cap31.31B
Market cap31.31B
Price-Earnings ratio18.14
Price-Earnings ratio18.14
Dividend yield1.43%
Dividend yield1.43%
Average volume235.60K
Average volume235.60K
High today$17.53
High today$17.53
Low today$17.14
Low today$17.14
Open price$17.45
Open price$17.45
Volume22.04K
Volume22.04K
52 Week high$27.50
52 Week high$27.50
52 Week low$14.98
52 Week low$14.98
DSNKY News
TipRanks 1d
Daiichi Sankyo Company Q1 2024 Earnings Report - Results, Call & Slides - TipRanks...
TipRanks 2d
DB-Guide Trial: AstraZeneca and Daiichi Sankyo Expand ENHERTU’s First-Line Breast Cancer StrategyAstraZeneca plc (GB:AZN), Daiichi Sankyo Company (DSKYF) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Pre...
Analyst ratings
88%
of 16 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.